Clinical Trial Update: A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating DCC-2618 in combination with Sunitinib in patients with advanced gastrointestinal stromal tumor after imatinib failure; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• DCC-2618
• Sunitinib (sunitinib)

Snippet

Sponsor: Zai Lab (Shanghai) Co., Ltd. | Conditions: Gastrointestinal Stromal Tumor(GIST) | Phase 2 | Status: COMPLETED | Results posted: 2025-01-15